These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 4906702

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Therapeutic guidelines and side effects encountered during L-dopa therapy in 100 cases of parkinsonism.
    Jenkins AC, Schwieger AC.
    Med J Aust; 1971 Oct 02; 2(14):693-700. PubMed ID: 5114186
    [No Abstract] [Full Text] [Related]

  • 25. Therapeutic uses and side effects of L-dopa.
    Boshes B.
    Adv Intern Med; 1972 Oct 02; 18():219-49. PubMed ID: 4576081
    [No Abstract] [Full Text] [Related]

  • 26. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University).
    Gutmann L, Martin JD, Gutrecht JA.
    W V Med J; 1970 Apr 02; 66(4):109-11. PubMed ID: 5264660
    [No Abstract] [Full Text] [Related]

  • 27. Sustained-release levodopa in parkinsonism.
    Eckstein B, Shaw K, Stern G.
    Lancet; 1973 Feb 24; 1(7800):431-2. PubMed ID: 4119747
    [No Abstract] [Full Text] [Related]

  • 28. [Side effects occurring in the course of treatment of parkinsonism with L-dopa].
    Kuran W.
    Neurol Neurochir Pol; 1973 Feb 24; 7(4):587-94. PubMed ID: 4583001
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of Parkinson's disease with L-dopa: a current appraisal.
    Kofman O.
    Can Med Assoc J; 1971 Mar 20; 104(6):483-7. PubMed ID: 5549988
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.
    Calne DB, Reid JL, Vakil SD, Rao S, Petrie A, Pallis CA, Gawler J, Thomas PK, Hilson A.
    Br Med J; 1971 Sep 25; 3(5777):729-32. PubMed ID: 4938431
    [Abstract] [Full Text] [Related]

  • 40. Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism.
    Mones RJ, Elizan TS, Siegel GJ.
    J Neurol Neurosurg Psychiatry; 1971 Dec 25; 34(6):668-73. PubMed ID: 5158780
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.